BioWorld Science

Aug. 24, 2001

View Archived Issues

Malaria vaccine MuStDO-5 found safe in preclinical studies

Read More

Role of Pgp and the MDR phenotype in gemtuzumab ozogamicin resistance characterized

Read More

CV Technologies' combination herbal product shows efficacy in ADHD

Read More

Medarex and Genesto to collaborate in developing therapeutic antibodies

Read More

Phase II/III study of Onco TCS passes safety review

Read More

Aventis and Millennium expand inflammatory disease drug development collaboration

Read More

Neuralstem and MetriGenix to develop stem cell-based neurochips for CNS drug discovery

Read More

Alliance updates Oxygent development

Read More

Dendreon and Kirin broaden cancer vaccine collaboration

Read More

Array BioPharma and Icos to discover and develop small-molecule allosteric regulators

Read More

Viread NDA set to be reviewed by Antiviral Advisory Committee in October

Read More

Genzyme and Theramed establish Canadian marketing collaboration for Thyrogen

Read More

Oxford GlycoSciences completes Vevesca NDA submission with FDA

Read More

Preliminary phase III results of IM-862 in KS disappointing

Read More

Cangene developing new drug technology platform

Read More

Intermune completes enrollment in phase III trial of Actimmune for treatment of IPF

Read More

Citrus flavonoid inhibits bone resorption

Read More

Genaera initiates first clinical trial for Lomucin

Read More

Versicor patents novel PDF inhibitors with antibacterial and antimicrobial activity

Read More

Serine protease inhibitors identified by researchers at AxyS

Read More

Sanofi-Synthelabo reports compounds useful for treating urinary incontinence

Read More

A new series of MMP inhibitors described by Darwin Discovery

Read More

Sumitomo designs new NHE inhibitors

Read More

Prevention of bone destruction by leflunomide

Read More